The role of fibroblast growth factor 23 in inflammation and anemia
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …
inflammation and anemia are contributing pathologies which increase the risks for …
An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles
H Ogata, A Takeshima, H Ito - Expert opinion on drug safety, 2022 - Taylor & Francis
Introduction Hyperphosphatemia is an inevitable complication for patients undergoing
dialysis, as is the resulting need for treatment with phosphate binders. Currently, various …
dialysis, as is the resulting need for treatment with phosphate binders. Currently, various …
[HTML][HTML] Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease
C Francis, G Courbon, C Gerber, S Neuburg, X Wang… - Kidney international, 2019 - Elsevier
Iron deficiency, anemia, hyperphosphatemia, and increased fibroblast growth factor 23
(FGF23) are common and interrelated complications of chronic kidney disease (CKD) that …
(FGF23) are common and interrelated complications of chronic kidney disease (CKD) that …
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients
M Ketteler, SM Sprague, AC Covic… - Nephrology Dialysis …, 2019 - academic.oup.com
Background Treatment of hyperphosphataemia is the primary goal of chronic kidney disease–
mineral and bone disorder (CKD-MBD) management. This post hoc analysis of a …
mineral and bone disorder (CKD-MBD) management. This post hoc analysis of a …
Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses
GA Block, PE Pergola, S Fishbane… - Nephrology Dialysis …, 2019 - academic.oup.com
Background Among patients with nondialysis-dependent chronic kidney disease (NDD-
CKD) and iron-deficiency anemia (IDA), ferric citrate increases hemoglobin and iron …
CKD) and iron-deficiency anemia (IDA), ferric citrate increases hemoglobin and iron …
Regulation of fibroblast growth factor 23 by iron, EPO, and HIF
JA Wheeler, EL Clinkenbeard - Current molecular biology reports, 2019 - Springer
Abstract Purpose of Review Fibroblast growth factor-23 (FGF23) is the key hormone
produced in bone critical for phosphate homeostasis. Elevated serum phosphorus and 1, 25 …
produced in bone critical for phosphate homeostasis. Elevated serum phosphorus and 1, 25 …
Phosphate wasting disorders in adults
A cause of hypophosphatemia is phosphate wasting disorders. Knowledge concerning
mechanisms involved in phosphate wasting disorders has greatly increased in the last …
mechanisms involved in phosphate wasting disorders has greatly increased in the last …
Ferric citrate for the treatment of hyperphosphatemia and anemia in patients with chronic kidney disease: a meta-analysis of randomized clinical trials
L Li, X Zheng, J Deng, J Zhou, J Ou, T Hong - Renal Failure, 2022 - Taylor & Francis
Background Hyperphosphatemia and anemia, which are common complications of chronic
kidney disease (CKD), can independently contribute to cardiovascular events. Several …
kidney disease (CKD), can independently contribute to cardiovascular events. Several …
New concepts in regulation and function of the FGF23
In comparison to the regulation of calcium homeostasis, which has been widely studied over
the last several decades, phosphate homeostasis is little understood. The parathyroid …
the last several decades, phosphate homeostasis is little understood. The parathyroid …
Crosstalk between fibroblast growth factor 23, iron, erythropoietin, and inflammation in kidney disease
JL Babitt, D Sitara - Current opinion in nephrology and …, 2019 - journals.lww.com
Regulation of FGF23 is complex and involves many bone and renal factors. More recently,
erythropoietin, iron deficiency, and inflammation have been also shown to affect FGF23 …
erythropoietin, iron deficiency, and inflammation have been also shown to affect FGF23 …